Four Thought Financial Partners, LLC Vertex Pharmaceuticals Inc Transaction History

Four Thought Financial Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $2,038 - $2,230	5 Added 0.39%	1,299 $543 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $17,923 - $19,210	-53 Reduced 3.93%	1,294 $450 Million
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $38,359 - $42,933	-122 Reduced 8.3%	1,347 $474 Million
Q1 2023 May 04, 2023	SELL	$283.23 - $323.1 $56,929 - $64,943	-201 Reduced 12.04%	1,469 $463 Million
Q4 2022 Feb 07, 2023	BUY	$285.76 - $321.48 $477,219 - $536,871	1,670 New	1,670 $482 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Four Thought Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Four Thought Financial Partners, LLC with notifications on news.